相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
Amy D. Shapiro et al.
BLOOD (2012)
Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia
P. W. Collins et al.
HAEMOPHILIA (2011)
Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1
Stefan Zeuzem et al.
GASTROENTEROLOGY (2010)
Diagnosis and quantification of factor VIII inhibitors
B. Verbruggen
HAEMOPHILIA (2010)
Half-life extension through albumin fusion technologies
Stefan Schulte
THROMBOSIS RESEARCH (2009)
A survey of adherence to haemophilia therapy in six European countries: results and recommendations
P. De Moerloose et al.
HAEMOPHILIA (2008)
Comparative study of validity of clinical, X-ray and magnetic resonance imaging scores in evaluation and management of haemophilic arthropathy in children
H Pergantou et al.
HAEMOPHILIA (2006)
Development of a long-acting insulin analog using albumin fusion technology
A Duttaroy et al.
DIABETES (2005)
A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia
J Ahnström et al.
HAEMOPHILIA (2004)
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
DA Roth et al.
BLOOD (2001)
Medical progress - The hemophilias - From royal genes to gene therapy
PM Mannucci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
